News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
finance.yahoo.com Deals and strategy
Sandoz has entered a collaboration agreement with Shanghai Henlius Biotech that will see the two companies work together on a slew of new biosimilars. The deal is milestones-based for a total consideration of up to $322m, with near-term payments associated with the initial assets that could reach up to $100.5m. Under the agreement, the two companies will collaborate …
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Brent oil trades near $88.7 per barrel amid a lack of significant news in the US-Iran conflict, according to Commerzbank Research in a note. Treasuries weakened into Friday's close but stabilized during Asian trading.A White House official says the situation in the conflict with …
Amazon has reinstated binding arbitration for its US customers, blocking them from bringing class-action lawsuits, Reuters reported, citing internal company emails. The revised terms took effect immediately, with the company telling customers that continued use of its services constitutes agreement to the changes. Disputes …
For Immediate Release Chicago, IL – August 17, 2026 – Zacks.com releases the list of companies likely to issue earnings surprises. This week's list includes Walmart WMT, Target TGT, Home Depot HD, Amazon AMZN, Micron MU and Alphabet GOOGL. Q2 Earnings Season Enters Final …
Sharemaestro market context Trend signal active 52 weeks +12.2%Alberta Investment Management Corp recently purchased 297,894 shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) valued at approximately $25.65 million, establishing a new position in the medical equipment provider. Other institutional investors also adjusted their holdings in ZBH, which currently has a "Hold" rating from …
Drug giant AstraZeneca has revealed its latest setback in just over a month after halting a late stage lung cancer treatment trial. The FTSE 100 firm said it found its Volrustomig drug, when combined with chemotherapy, was unlikely to boost survival rates for lung …
[A big sign with AstraZeneca logotype outside the entrance.] Wirestock * AstraZeneca (AZN [https://seekingalpha.com/symbol/AZN]) is discontinuing its eVOLVE-Lung02 Phase III trial of volrustomig plus chemotherapy in metastatic non-small cell lung cancer after an independent committee concluded the drug was unlikely to meet either primary …
Collaboration may cover up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar assets, with the majority of programs at early development stages Based on the initial arrangements, the total invoiced amount expected to be achieved by Henlius in 2026 is up …
Sharemaestro market context Trend signal active 43 weeks +45.5% · Next-week setup positive 56.0%Transforming the Research Lifecycle Through Integrated Data Management, Advanced Automation, and AI-Driven Workflows TOKYO, Aug. 16, 2026 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it will support the introduction and implementation of Benchling, the AI platform for R&D at Tokyo Research Park and …
Sharemaestro market context Price below Trend Line 52 weeks -29.0% · Next-week setup negative 25.7%Q2 Earnings Roundup: Energizer (NYSE:ENR) And The Rest Of The Household Products Segment Let's dig into the relative performance of Energizer (NYSE:ENR) and its peers as we unravel the now-completed Q2 household products earnings season. Household products stocks are generally stable investments, as many …
Amazon (NASDAQ: AMZN), Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), and Microsoft (NASDAQ: MSFT) are the world's three biggest cloud computing providers. They are spending a ton of money on adding more computing capacity this year, with Amazon leading the way, on track to spend $220 …
Zoom (ZM): Buy, Sell, or Hold Post Q1 Earnings? Over the past six months, Zoom has been a great trade, beating the S&P 500 by 10.4%. Its stock price has climbed to $109.49, representing a healthy 23.5% increase. This was partly due to its …
This article examines three AI healthcare stocks—Pfizer, Tempus AI, and Stryker—that are positioned for productivity growth in a high bond yield environment. It highlights Pfizer's deep pipeline and AI R&D efforts despite patent expiry pressures, Tempus AI's platform leveraging genomic and clinical data for …
Turkcell Iletisim Hizmetleri AS (NYSE:TKC) saw a significant increase in short interest during July, nearly doubling to 3.02 million shares, representing 0.3% of outstanding shares and a 0.9 days-to-cover ratio. Despite this, the stock rose 1.0% to $5.47, trading near its 12-month low, and …
Sezzle (SEZL) recently raised its full-year 2026 total revenue growth guidance to 35% and secured a new US$300 million credit facility, following a 26.17% share price pullback over 30 days but a 97.94% year-to-date return. Despite these positive developments, a popular narrative suggests Sezzle …
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Recent Share Price Context for Zhejiang Leapmotor Technology Zhejiang Leapmotor Technology (SEHK:9863) has drawn …
Search by ticker symbol or company name and select a result to open its chart.